Eva J A Morris1, Raphael Goldacre2, Enti Spata3, Marion Mafham2, Paul J Finan4, Jon Shelton5, Mike Richards5, Katie Spencer6, Jonathan Emberson3, Sam Hollings7, Paula Curnow7, Dominic Gair7, David Sebag-Montefiore4, Chris Cunningham8, Matthew D Rutter9, Brian D Nicholson10, Jem Rashbass7, Martin Landray2, Rory Collins2, Barbara Casadei11, Colin Baigent3. 1. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK. Electronic address: eva.morris@ndph.ox.ac.uk. 2. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK. 3. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK. 4. Leeds Teaching Hospitals NHS Trust, Leeds, UK; Leeds Institute for Medical Research at St James's, University of Leeds, Leeds, UK. 5. Cancer Research UK, London, UK. 6. Leeds Teaching Hospitals NHS Trust, Leeds, UK; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. 7. NHS Digital, Leeds, UK. 8. Department of Colorectal Surgery, Oxford University Hospitals, Oxford, UK. 9. Population Health Sciences Institute, University of Newcastle, Newcastle, UK; Department of Gastroenterology, North Tees University Hospital NHS Trust, Stockton on Tees, UK. 10. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. 11. Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK.
Abstract
BACKGROUND: There are concerns that the COVID-19 pandemic has had a negative effect on cancer care but there is little direct evidence to quantify any effect. This study aims to investigate the impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England. METHODS: Data were extracted from four population-based datasets spanning NHS England (the National Cancer Cancer Waiting Time Monitoring, Monthly Diagnostic, Secondary Uses Service Admitted Patient Care and the National Radiotherapy datasets) for all referrals, colonoscopies, surgical procedures, and courses of rectal radiotherapy from Jan 1, 2019, to Oct 31, 2020, related to colorectal cancer in England. Differences in patterns of care were investigated between 2019 and 2020. Percentage reductions in monthly numbers and proportions were calculated. FINDINGS: As compared to the monthly average in 2019, in April, 2020, there was a 63% (95% CI 53-71) reduction (from 36 274 to 13 440) in the monthly number of 2-week referrals for suspected cancer and a 92% (95% CI 89-95) reduction in the number of colonoscopies (from 46 441 to 3484). Numbers had just recovered by October, 2020. This resulted in a 22% (95% CI 8-34) relative reduction in the number of cases referred for treatment (from a monthly average of 2781 in 2019 to 2158 referrals in April, 2020). By October, 2020, the monthly rate had returned to 2019 levels but did not exceed it, suggesting that, from April to October, 2020, over 3500 fewer people had been diagnosed and treated for colorectal cancer in England than would have been expected. There was also a 31% (95% CI 19-42) relative reduction in the numbers receiving surgery in April, 2020, and a lower proportion of laparoscopic and a greater proportion of stoma-forming procedures, relative to the monthly average in 2019. By October, 2020, laparoscopic surgery and stoma rates were similar to 2019 levels. For rectal cancer, there was a 44% (95% CI 17-76) relative increase in the use of neoadjuvant radiotherapy in April, 2020, relative to the monthly average in 2019, due to greater use of short-course regimens. Although in June, 2020, there was a drop in the use of short-course regimens, rates remained above 2019 levels until October, 2020. INTERPRETATION: The COVID-19 pandemic has led to a sustained reduction in the number of people referred, diagnosed, and treated for colorectal cancer. By October, 2020, achievement of care pathway targets had returned to 2019 levels, albeit with smaller volumes of patients and with modifications to usual practice. As pressure grows in the NHS due to the second wave of COVID-19, urgent action is needed to address the growing burden of undetected and untreated colorectal cancer in England. FUNDING: Cancer Research UK, the Medical Research Council, Public Health England, Health Data Research UK, NHS Digital, and the National Institute for Health Research Oxford Biomedical Research Centre.
BACKGROUND: There are concerns that the COVID-19 pandemic has had a negative effect on cancer care but there is little direct evidence to quantify any effect. This study aims to investigate the impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England. METHODS: Data were extracted from four population-based datasets spanning NHS England (the National Cancer Cancer Waiting Time Monitoring, Monthly Diagnostic, Secondary Uses Service Admitted Patient Care and the National Radiotherapy datasets) for all referrals, colonoscopies, surgical procedures, and courses of rectal radiotherapy from Jan 1, 2019, to Oct 31, 2020, related to colorectal cancer in England. Differences in patterns of care were investigated between 2019 and 2020. Percentage reductions in monthly numbers and proportions were calculated. FINDINGS: As compared to the monthly average in 2019, in April, 2020, there was a 63% (95% CI 53-71) reduction (from 36 274 to 13 440) in the monthly number of 2-week referrals for suspected cancer and a 92% (95% CI 89-95) reduction in the number of colonoscopies (from 46 441 to 3484). Numbers had just recovered by October, 2020. This resulted in a 22% (95% CI 8-34) relative reduction in the number of cases referred for treatment (from a monthly average of 2781 in 2019 to 2158 referrals in April, 2020). By October, 2020, the monthly rate had returned to 2019 levels but did not exceed it, suggesting that, from April to October, 2020, over 3500 fewer people had been diagnosed and treated for colorectal cancer in England than would have been expected. There was also a 31% (95% CI 19-42) relative reduction in the numbers receiving surgery in April, 2020, and a lower proportion of laparoscopic and a greater proportion of stoma-forming procedures, relative to the monthly average in 2019. By October, 2020, laparoscopic surgery and stoma rates were similar to 2019 levels. For rectal cancer, there was a 44% (95% CI 17-76) relative increase in the use of neoadjuvant radiotherapy in April, 2020, relative to the monthly average in 2019, due to greater use of short-course regimens. Although in June, 2020, there was a drop in the use of short-course regimens, rates remained above 2019 levels until October, 2020. INTERPRETATION: The COVID-19 pandemic has led to a sustained reduction in the number of people referred, diagnosed, and treated for colorectal cancer. By October, 2020, achievement of care pathway targets had returned to 2019 levels, albeit with smaller volumes of patients and with modifications to usual practice. As pressure grows in the NHS due to the second wave of COVID-19, urgent action is needed to address the growing burden of undetected and untreated colorectal cancer in England. FUNDING: Cancer Research UK, the Medical Research Council, Public Health England, Health Data Research UK, NHS Digital, and the National Institute for Health Research Oxford Biomedical Research Centre.
Authors: Maximilian Brunner; Christian Krautz; Stephan Kersting; Georg F Weber; Benno Stinner; Stefan R Benz; Robert Grützmann Journal: Int J Colorectal Dis Date: 2020-07-29 Impact factor: 2.571
Authors: Marco Caricato; Gian Luca Baiocchi; Francesco Crafa; Stefano Scabini; Giuseppe Brisinda; Marco Clementi; Giuseppe Sica; Paolo Delrio; Graziano Longo; Gabriele Anania; Nicolò de Manzini; Pietro Amodio; Andrea Lucchi; Gianandrea Baldazzi; Gianluca Garulli; Alberto Patriti; Felice Pirozzi; Maurizio Pavanello; Alessandro Carrara; Roberto Campagnacci; Andrea Liverani; Andrea Muratore; Walter Siquini; Raffaele De Luca; Stefano Mancini; Felice Borghi; Mariantonietta Di Cosmo; Roberto Persiani; Corrado Pedrazzani; Matteo Scaramuzzi; Marco Scatizzi; Nereo Vettoretto; Mauro Totis; Andrea Gennai; Pierluigi Marini; Massimo Basti; Massimo Viola; Giacomo Ruffo; Marco Catarci Journal: Updates Surg Date: 2020-05-20
Authors: Scott C Fligor; Sophie Wang; Benjamin G Allar; Savas T Tsikis; Ana Sofia Ore; Ashlyn E Whitlock; Rodrigo Calvillo-Ortiz; Kevin R Arndt; Sidhu P Gangadharan; Mark P Callery Journal: J Gastrointest Surg Date: 2020-06-30 Impact factor: 3.452
Authors: C A M Marijnen; F P Peters; C Rödel; K Bujko; K Haustermans; E Fokas; R Glynne-Jones; V Valentini; K-L G Spindler; M G Guren; Philippe Maingon; F A Calvo; O Pares; B Glimelius; D Sebag-Montefiore Journal: Radiother Oncol Date: 2020-04-02 Impact factor: 6.280
Authors: A Sud; M E Jones; J Broggio; C Loveday; B Torr; A Garrett; D L Nicol; S Jhanji; S A Boyce; F Gronthoud; P Ward; J M Handy; N Yousaf; J Larkin; Y-E Suh; S Scott; P D P Pharoah; C Swanton; C Abbosh; M Williams; G Lyratzopoulos; R Houlston; C Turnbull Journal: Ann Oncol Date: 2020-05-19 Impact factor: 32.976
Authors: S McPhail; L Elliss-Brookes; J Shelton; A Ives; M Greenslade; S Vernon; E J A Morris; M Richards Journal: Br J Cancer Date: 2013-09-17 Impact factor: 7.640
Authors: Chey Loveday; Amit Sud; Michael E Jones; John Broggio; Stephen Scott; Firza Gronthound; Beth Torr; Alice Garrett; David L Nicol; Shaman Jhanji; Stephen A Boyce; Matthew Williams; Claire Barry; Elio Riboli; Emma Kipps; Ethna McFerran; David C Muller; Georgios Lyratzopoulos; Mark Lawler; Muti Abulafi; Richard S Houlston; Clare Turnbull Journal: Gut Date: 2020-08-27 Impact factor: 23.059
Authors: Nazrul Islam; Vladimir M Shkolnikov; Rolando J Acosta; Ilya Klimkin; Ichiro Kawachi; Rafael A Irizarry; Gianfranco Alicandro; Kamlesh Khunti; Tom Yates; Dmitri A Jdanov; Martin White; Sarah Lewington; Ben Lacey Journal: BMJ Date: 2021-05-19
Authors: R E Clifford; D Harji; L Poynter; R Jackson; R Adams; N S Fearnhead; D Vimalachandran Journal: Br J Surg Date: 2021-05-07 Impact factor: 6.939
Authors: Lauren J Scott; Mairead Murphy; Sarah Price; Rhys Lewis; Rachel Denholm; Jeremy Horwood; Tom Palmer; Chris Salisbury Journal: BMJ Open Date: 2021-05-24 Impact factor: 3.006
Authors: Jemma M Boyle; Angela Kuryba; Helen A Blake; Ajay Aggarwal; Jan van der Meulen; Kate Walker; Michael Braun; Nicola Fearnhead Journal: Colorectal Dis Date: 2021-04-08 Impact factor: 3.917
Authors: Ju Yeon Choi; In Ja Park; Hyun Gu Lee; Eunhae Cho; Young Il Kim; Chan Wook Kim; Yong Sik Yoon; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim Journal: Cancers (Basel) Date: 2021-05-06 Impact factor: 6.639
Authors: Sofía Ruiz-Medina; Silvia Gil; Begoña Jimenez; Pablo Rodriguez-Brazzarola; Tamara Diaz-Redondo; Mireya Cazorla; Marta Muñoz-Ayllon; Inmaculada Ramos; Carmen Reyna; María José Bermejo; Ana Godoy; Esperanza Torres; Manuel Cobo; Laura Galvez; Antonio Rueda; Emilio Alba; Nuria Ribelles Journal: Cancers (Basel) Date: 2021-06-28 Impact factor: 6.575